Detalles de la búsqueda
1.
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.
Pediatr Blood Cancer
; 69(4): e29511, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129294
2.
The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Cancer
; 125(2): 290-297, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30351457
3.
Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.
Cancer
; 124(9): 1973-1981, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29461635
4.
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 64(12)2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28521080
5.
Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging.
Pediatr Radiol
; 47(4): 484-487, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28144704
6.
Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group.
J Surg Oncol
; 113(4): 351-4, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26776342
7.
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
Pediatr Blood Cancer
; 63(1): 54-61, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26398490
8.
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.
Pediatr Blood Cancer
; 63(4): 634-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26756883
9.
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.
Pediatr Blood Cancer
; 63(10): 1737-43, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27128693
10.
Myogenic tumors in nevoid Basal cell carcinoma syndrome.
J Pediatr Hematol Oncol
; 37(2): 147-9, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24517962
11.
Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.
Cancer
; 120(7): 1068-75, 2014 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24382691
12.
Mutations in Hedgehog pathway genes in fetal rhabdomyomas.
J Pathol
; 231(1): 44-52, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23780909
13.
Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney.
Pediatr Nephrol
; 29(11): 2139-46, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24865477
14.
Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature.
J Neuroophthalmol
; 34(1): 39-43, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24284555
15.
Splenic Lymphatic Malformation With Papillary Endothelial Proliferation: A Rare Histologic Variant or a Unique Entity?
Am J Surg Pathol
; 47(8): 915-925, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37334821
16.
Left ventricular aneurysm, aortic stenosis, and arcade mitral valve: coexistence of three rare congenital heart defects.
Pediatr Cardiol
; 33(7): 1206-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22388513
17.
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.
Eur J Cancer
; 172: 264-275, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35809374
18.
Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma.
Arch Pathol Lab Med
; 145(12): 1564-1568, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33769463
19.
The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group.
Eur J Cancer
; 143: 127-133, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33302115
20.
Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Cancer Med
; 10(3): 857-866, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340280